Abstract
The GHRH test represents a new tool in the study of secretion in man. Nine normal fasting males received on separate occasions in random order 1) GHRH 1–40 (1 μg/Kg bw) iv at time 0; 2) TRH (6 μg/min) infusion between −30 and+120 min; 3) GHRH 1–40(1 μg/Kg bw) iv at time 0 plus TRH (6 μg/min) infusion between −30 and + 120 min. Blood samples were drawn for GH, PRL and TSH at −90, −60, −30, 0 min and then every 15 mm for 2 h. GHRH significantly increased GH in all subjects. The same GH response was found during GHRH plus TRH test. No effect was found either on PRL and TSH secretion after GHRH administration, or on GH pattern after TRH administration. A significant decrease of TSH, but not of PRL response was observed after GHRH plus TRH administration in comparison to TRH alone. These results underline that the inhibitory effect exerted by TRH on GH secretion during some experimental conditions is not linked to a pituitary interference between GHRH and TRH. The difference in TSH secretion, following GHRH plus TRH in comparison with TRH alone, could be due to a GHRH-induced central inhibitory mechanism, probably GHRIH-related.
Similar content being viewed by others
References
Maeda K., Kato Y., Chihara K., Orgo S., Iwasaki Y., Abe A., Imura H. Suppression by thyrotropin-releasing hormone (TRH) of growth hormone release induced by arginine and insulin-induced hypoglycemia in man. J. Clin. Endocrinol. Metab. 43: 453, 1976.
Hainer V., Urbanek J., Malec B., Krejcik A. The effect of TRH, cyproheptadine and pimozide on the growth hormone response to intramuscular glucagon. Horm. Metab. Res. 13: 451, 1981.
Maeda K., Kato Y., Chihara K., Ohgo S., Okanishi Y., Imura H. Suppressive effect of thyrotropin-releasing hormone (TRH) on human growth hormone release induced by L-Dopa. J. Clin. Endocrinol. Metab. 41: 408, 1975.
Brown P.M., Bacchus R., Sachs L., Sonksen P.H, Wheeler M. Bromocriptine suppression of TRH-stimulated prolactin and thyrotropin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man. Clin. Endocrinol. (Oxf.) 10: 481, 1979.
Chihara K., Kato Y., Maeda K., Abe H., Furamoto M., Imura H. Effects of thyrotropin-releasing hormone on sleep and sleep-releated growth hormone release in normal subjects. J. Clin. Endocrinol. Metab. 44: 1094, 1977.
Guillemin R., Brazeau P., Bohlen P., Esch F., Ling N., Wehrenberg W.G. Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science 218: 585, 1982.
Rivier J., Spiess J., Thorner M., Vale W. Characterization of a growth hormone-releasing factor from human pancreatic islet tumour. Nature 300: 276, 1982.
Ling N., Esch F., Bohlen P., Brazeau P., Wehrenberg W.B., Guillemin R. Isolation, primary structure and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc. Natl. Acad. Sci. USA 81: 4302, 1984.
Bilezikjian L.H., Vale W. Stimulation of adenosine 3′5′-monophosphate production by growth hormone-releasing factor and its inhibition by somatostatin in anterior pituitary cells in vitro. Endocrinology 113: 1726, 1983.
Giusti M., Mazzocchi G., Sessarego P., Mignone D., Lomeo A., Monachesi M., Giordano G. Effects of GRF (1–40) and domperidone on GH secretion in normal man. Clin. Endocrinol (Oxf.) 21: 339, 1984.
Giusti M., Mazzocchi G., Mignone D., Tarditi, W., Contessini M., Bessarione D., Giordano G. The effect of nomifensine on thyroid-stimulating hormone (TSH) in normal and hyperprolactinemic subjects. Neuroendocrinology 27: 406, 1983.
Sowers J.R., Hershman J.M., Carlson H.E., Pekary A.E., Naair M.G., Bauch C.H.M. Prolactin response to N3IM-Methyl thyrotropin releasing hormone in euthyroid subjects. J. Clin. Endocrinol. Metab. 43: 749, 1976.
Armitage P. Statistica medica. Metodi statistici per la ricerca in medicina. G. Feltrinelli, Milano, 1982, p. 215.
Evain Brion D., Garner P.H., Schimpff R.M., Chaussain J.L., Job J.C. Growth hormone response to thyrotropin-releasing hormone and oral glucose loading tests in tall children and adolescents. J. Clin. Endocrinol. Metab. 56: 429, 1983.
Knigge U., Thuesen D., Wollesen F., Dejgaard A., Christiansen P.M. Histamine-induced paradoxical growth hormone response to thyrotropin-releasing hormone in normal man., J. Clin. Endocrinol. Metab. 58: 692, 1984.
Faglia G., Beck-Peccoz P., Ferrari C., Travaglini P., Ambrosi B., Spada A. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly. J. Clin. Endocrinol. Metab. 36 1259, 1973.
Irie M., Tsushima T. Increase of serum growth hormone concentration following thyrotropin releasing hormone injection in patients with acromegaly or gigantism. J. Clin. Endocrinol. Metab. 35: 97, 1972.
Giordano G., Giusti M. La partecipazione del sistema nervoso centrale nella patogenesi delle sindromi da carenza o eccesso di secrezione somatotropa. In: Müller E.E. (Ed.), Neuroendocrinologia aspetti sperimentali e clinici. Edizioni Medico Scientifiche Intemazionali, Roma, 1984 p. 335.
Anderson M.S., Bowers C.Y., Kastin A.J., Schalch D.S., Schally A.V., Snyder P.G., Utiger R.D., Wilber J.F., Wise A.J. Synthetic thyrotropin-releasing hormone. A potent stimulator for thyrotropin secretion in man. N. Engl. J. Med. 285: 1279, 1971.
Thorner M.O., Rivier J., Spiess J., Borges J.L., Vance M.L., Bloom S.R., Rogol A.D., Cronin M.J., Kaiser D.L., Evans W.S., Webster J.D., MacLeod R.M., Vale W. Human pancreatic growth hormone releasing factor selectively stimulates growth hormone secretion in man. Lancet 1: 24, 1983.
Wehrenberg W.B., Baird A., Ying S.Y., Rivier C., Ling N., Guillemin R. Multiple stimulation of the adenohypophysis by combination of hypothalamic releasing factors. Endocrinology 114: 1995, 1985.
Sheldon W.R. jr, De Bold C.R., Evans W.S., De Cherney G.S., Jackson R.V., Island D.P., Thorner M.O., Orth D.N. Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects. J. Clin. Endocrinol. Metab. 60: 623, 1985.
Guglielmino L., Arosio M., Bazzoni N., Faglia G. Additive effect of GRF and TRH combined administration on serum GH levels in TRH responsive acromegalic patients. J. Endocrinol. Invest. 8(Suppl. 1): 42, 1985.
Adams E.F., Bhuttacharji S.C., Halliwell C.L.J., Loizou M., Birch G., Mashiter K. Effect of pancreatic growth hormone releasing factors on GH secretion by human somatotrophic pituitary tumours in cell culture. Clin. Endocrinol (Oxf.) 21: 709, 1984.
Ho K.Y., Smithe G.A., Lazarus L. The interaction of TRH and dopaminergic mechanisms in the regulation of stimulated prolactin release in man. Clin. Endocrinol. (Oxf) 23: 7, 1985.
Mongioi A., Aliffi A., Vicari E., Coniglione F., Scapagnini U., D’Agata R. Down regulation of prolactin secretion in men during continuous thyrotropin-releasing hormonr infusion: evidence for induction of pituitary sensitization by continuous TRH administration. J. Clin. Endocrinol. Metab. 56: 904, 1983.
Aguila M.C., McCann S.M. Stimulation of somatostatin release in vitro by sinthetic human growth hormone-releasing factor by a nondo-paminergic mechanism. Endocrinology 117: 762, 1985.
Chihara K., Minamitami N., Kaji H., Arimura A., Fujika T. Intraventricular injected growth hormone stimulates somatostatin release into rat hypophyseal portal blood. Endocrinology 109: 2279, 1981.
Rosenthal S.M., Hulse J.A., Kaplan M.M. Exogenous growth hormone (GH) inhibits growth hormone-releasing factor (GRF-44-NH2)-induced GH secretion in normal men: further evidence for GH autoregulation. Proceedings of 7th International Congress of Endocrinology, July 1–7, Quebec City, 1984, p. 1144.
Hershman J.M., Pekary A.E. Regulation of thyrotropin secretion. In: Imura H. (Ed.), The pituitary gland. Raven Press, New York, 1985, p. 149.
Carr D., Gomez-Pan A., Weightman D.R., Roy V.C.M., Hall R., Besser G.M., Thomer M.O., McNelly A.S., Schally A.V., Kastin A.J., Coy D.H. Growth hormone release inhibiting hormone: actions on thyrotropin and prolactin secretion after thyrotrophin-releasing hormone. Br. Med. J. 3: 67, 1975.
Siler T.M., Yen S.S.C., Vale W., Guillemin R. Inhibition by somatostatin on the release of TSH induced in men by thyrotropin-releasing factor. J. Clin. Endocrinol. Metab. 38: 742, 1974.
Thomas C.R., Groot K., Arimura A. Antiserum to rat growth hormone (GH) — releasing factor suppresses but does not abolish antisomatostatin-induced GH release in the rat. Endocrinology 116: 2174, 1985.
Looij B.J. jr., Nieuwenhuijzen Kruseman A.C., Mudde A.H., Froelich M., Piaditis G.P., Hodgkinson S.C., McLean C., Grossman A., Coy D.H., Rees L.H., Lowry P.J., Besser G.M. The interactions, of growth hormone-releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin. Endocrinol. (Oxf.) 24: 149, 1986.
Tangolo D., Molinatti P., Careddu D., Pogliano G.F., Molinatti G.M. Effect of TRH on GH respone to GHRH in normal subjects. J. Endocrinol. Invest. 9(Suppl. 1): 243, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giusti, M., Lomeo, A., Mazzocchi, G. et al. Effect of simultaneous administration of GHRH (1–40) and TRH on GH, PRL and TSH secretion in normal man. J Endocrinol Invest 9, 497–501 (1986). https://doi.org/10.1007/BF03346973
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346973